CBI’s 2nd Annual Data Analytics and Decisions focuses on data analytics to make strategic business decisions that will strengthen compliance monitoring and improve commercial business performance. Currently, bio/pharmaceutical and device companies are focused on streamlining their data collection practices, determining the metrics to focus on, choosing how to visualize results and analyzing best practices to filter the results. This program offers the opportunity for those with a focus on analytics, monitoring, and IT to further discuss how to integrate new technologies into the decision making of bio/pharmaceutical and device companies.
To learn more, click here.
Moderator - Michael O'Connor
"ROUNDTABLE DISCUSSION: Small-Mid Size Pharma Perspectives on Enhancing Data Analytics"
Day 1 - January 23 @ 2:30 pm
Speak - Michael O'Connor
"Leverage A.I. and New Innovations to Enhance Efficiency in Compliance Data Analytics"
Day 1 - January 23 @ 4:45